☆ 4.7 Meeting Abstract

AN OPEN-LABEL STUDY TO EVALUATE BIOMARKERS AND SAFETY IN SYSTEMIC SCLEROSIS (SSC) PATIENTS TREATED WITH PAQUINIMOD (ABR-215757)

ANNALS OF THE RHEUMATIC DISEASES (2014)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 73, 期 -, 页码 566-567

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2014-eular.4207

关键词

-

类别

Rheumatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Rheumatology

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Roger Hesselstrand, Joerg H. W. Distler, Gabriela Riemekasten, Dirk M. Wuttge, Marie Torngren, Helen C. Nyhlen, Fredrik Andersson, Helena Eriksson, Birgitta Sparre, Helen Tuvesson, Oliver Distler

Summary: The study found that in patients with SSc, treatment with paquinimod reduced the activity of type I IFN in both plasma and skin, decreased serum levels of CCL2, and reduced the number of myofibroblasts. There were no significant changes in modified Rodnan skin score and quality of life during treatment. Adverse events were mostly mild to moderate and expected.

ARTHRITIS RESEARCH & THERAPY (2021)

添加到收藏夹

Article Clinical Neurology

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

Scott D. Newsome, Fan Tian, Thomas Shoemaker, Kathryn C. Fitzgerald, Sandra D. Cassard, Julie Fiol, Sarah Snoops, David S. Cooper, Jennifer S. R. Mammen, Pavan Bhargava, Ellen M. Mowry, Peter A. Calabresi

Summary: Thyroid hormones play a crucial role in myelination during development and may have reparative effects in the adult central nervous system. A phase 1b clinical trial on individuals with MS showed that liothyronine, a synthetic form of T3, was well-tolerated and safe. The treatment did not lead to severe adverse events or disease activation. CSF proteomic changes suggested a biological effect of T3 treatment, particularly on immune cell function and angiogenesis. Further studies are needed to assess the potential of liothyronine in promoting remyelination and improving function in MS.

NEUROTHERAPEUTICS (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Lipid Alterations in Systemic Sclerosis

Zuzanna Gogulska, Zaneta Smolenska, Jacek Turyn, Adriana Mika, Zbigniew Zdrojewski

Summary: This review summarized studies on lipidomics in systemic sclerosis, focusing on lipoproteins, fatty acids, cholesterol, and other components, highlighting their potential role in the disease pathology.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Review Rheumatology

Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis

Maliheh Moradzadeh, Mehrdad Aghaei, Zahra Mehrbakhsh, Zahra Arab-Bafrani, Nafiseh Abdollahi

Summary: This meta-analysis demonstrates that rituximab can improve skin score and disease indices, and stabilize organ involvement in SSc patients. Despite some safety concerns, rituximab appears to have reasonable safety in SSc patients. The pooled analysis showed long-term improvement in certain parameters, indicating the potential efficacy of rituximab in the treatment of SSc.

CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Biochemical Research Methods

Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis

Chenxi Liu, Guang Song, Songxin Yan, Yangzhige He, Chaojun Hu, Yong Hou, Xiaoting Wen, Liubing Li, Fengchun Zhang, Heng Zhu, Yongzhe Li

Summary: A novel autoantibody, anti-SNRPA, has been identified and validated as a potential biomarker for diagnosing systemic sclerosis, using a protein array-based approach.

JOURNAL OF PROTEOME RESEARCH (2023)

添加到收藏夹

Article Immunology

Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice

Xiaoyang Yue, Frank Petersen, Yaqing Shu, Brigitte Kasper, Junie D. Tchudjin Magatsin, Marjan Ahmadi, Junping Yin, Jacqueline Wax, Xiaoqing Wang, Harald Heidecke, Peter Lamprecht, Antje Mueller, Xinhua Yu, Gabriela Riemekasten

Summary: This study highlights the crucial role of B cells and sustained autoimmunity in the pathogenesis of SSc, demonstrated through a humanized mouse model. It provides a powerful tool for studying interstitial lung disease and other disease manifestations such as myositis and interstitial nephritis.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Health Care Sciences & Services

Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis

Giorgia Leodori, Chiara Pellicano, Valerio Basile, Amalia Colalillo, Luca Navarini, Antonietta Gigante, Francesca Gulli, Mariapaola Marino, Umberto Basile, Edoardo Rosato

Summary: This study aimed to evaluate the longitudinal association between basal serum adiponectin and skin thickness in systemic sclerosis (SSc) patients. The results showed a correlation between decreased serum adiponectin levels and increased skin thickness.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Oncology

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

P. Grivas, Y. Loriot, R. Morales-Barrera, M. Y. Teo, Y. Zakharia, S. Feyerabend, N. J. Vogelzang, E. Grande, N. Adra, A. Alva, A. Necchi, A. Rodriguez-Vida, S. Gupta, D. H. Josephs, S. Srinivas, K. Wride, D. Thomas, A. Simmons, A. Loehr, R. L. Dusek, D. Nepert, S. Chowdhury

Summary: Rucaparib did not demonstrate significant activity in advanced UC patients, regardless of HRD status. The safety profile was consistent with observations in ovarian or prostate cancer patients.

BMC CANCER (2021)

添加到收藏夹

Article Immunology

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis

Tjalf Ziemssen, Eugen Schlegel, Marie Groth, Benjamin Ettle, Tobias Bopp

Summary: Booster vaccinations increase neutralizing antibody titers in ofatumumab-treated patients. A booster is recommended in ofatumumab-treated patients.

VACCINES (2023)

添加到收藏夹

Review Immunology

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?

Aurelien Chepy, Louisa Bourel, Vincent Koether, David Launay, Sylvain Dubucquoi, Vincent Sobanski

Summary: Systemic sclerosis (SSc) is a connective tissue disease characterized by extensive fibrosis of the skin and internal organs. Antinuclear antibodies (ANA) are found in almost all SSc patients, but the exact role they play in the disease remains unclear. However, studies have shown that ANA may be associated with disease subtypes, appear before disease onset, correlate with disease activity and severity, and have a response to B-cell targeting therapy.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

Bianca Saveria Fioretto, Irene Rosa, Marco Matucci-Cerinic, Eloisa Romano, Mirko Manetti

Summary: Systemic sclerosis (SSc, scleroderma) is a rare connective tissue disease characterized by immune dysregulation, small vessel vasculopathy, impaired angiogenesis, and fibrosis. Microvascular impairment is the initial event of the disease and is linked to disabling and life-threatening clinical manifestations. Despite available treatment options, managing SSc-related vascular disease remains challenging. Vascular biomarkers have shown promise in assessing disease progression, predicting prognosis, and guiding therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Medicine, General & Internal

Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis

Jiangfan Yu, Rui Tang, Ke Ding

Summary: Systemic sclerosis is a rare chronic autoimmune disease that involves genetic and environmental factors, as well as the influence of epigenetic regulation.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

添加到收藏夹

Article Rheumatology

Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis

Apichart Jantarat, Chayawee Muangchan

Summary: The study found significant differences in characteristics of systemic sclerosis (SSc) overlap syndrome (SSc-OS), with associations with limited cutaneous subset and specific laboratory markers. The most common overlap syndrome associated with SSc-OS was rheumatoid arthritis (RA).

MODERN RHEUMATOLOGY (2022)

添加到收藏夹

Article Immunology

Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp

Summary: This study investigated the immune response in multiple sclerosis (MS) patients receiving ofatumumab after SARS-CoV-2 mRNA vaccination. The results showed that these patients were able to mount a T-cell response and increase levels of neutralizing antibodies, although it was slightly less pronounced compared to the control group.

VACCINES (2022)

添加到收藏夹

Article Medicine, General & Internal

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis

Liticia Chikhoune, Thierry Brousseau, Sandrine Morell-Dubois, Meryem Maud Farhat, Helene Maillard, Emmanuel Ledoult, Marc Lambert, Cecile Yelnik, Sebastien Sanges, Vincent Sobanski, Eric Hachulla, David Launay

Summary: This study aimed to assess the association of routine laboratory parameters with the severity and progression of systemic sclerosis (SSc). The results showed that certain routine laboratory parameters were associated with different clinical presentations and outcomes of SSc.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Rheumatology

The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease?

Elisabeth Blaja, Suzana Jordan, Carmen-Marina Mihai, Rucsandra Dobrota, Mike Oliver Becker, Britta Maurer, Marco Matucci-Cerinic, Oliver Distler

Summary: The study demonstrated that very early systemic sclerosis (SSc) patients are a heterogeneous group with mild or early disease, showing diverse clinical presentations. Some patients may have long-standing mild disease, and there was no difference in clinical features at initial presentation between patients with potentially progressive disease and those with long-standing mild disease. These findings highlight the importance of considering the heterogeneity of very early SSc patients for risk stratification and study design.

JOURNAL OF RHEUMATOLOGY (2021)

添加到收藏夹

Letter Rheumatology

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

Dinesh Khanna, Oliver Distler

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Review Rheumatology

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Paolo Spagnolo, Oliver Distler, Christopher J. Ryerson, Argyris Tzouvelekis, Joyce S. Lee, Francesco Bonella, Demosthenes Bouros, Anna-Maria Hoffmann-Vold, Bruno Crestani, Eric L. Matteson

Summary: This study discusses the different types of interstitial lung diseases (ILDs) and their association with autoimmune and connective tissue diseases (CTDs), as well as introduces drug treatment studies for some fibrosing ILDs. It emphasizes the importance of fibrosis in ILDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Clinical Neurology

No evidence for an effect of working from home on neck pain and neck disability among Swiss office workers: Short-term impact of COVID-19

Andrea M. Aegerter, Manja Deforth, Venerina Johnston, Gisela Sjogaard, Thomas Volken, Hannu Luomajoki, Julia Dratva, Holger Dressel, Oliver Distler, Achim Elfering, Markus Melloh

Summary: Working from home during the COVID-19 pandemic did not show clinically relevant changes in neck pain intensity and disability. The number of work breaks and hours spent at the computer were found to have a greater effect on neck pain than the place of work or workstation ergonomics. Further research should investigate the impact of social and psychological factors on neck pain among office workers.

EUROPEAN SPINE JOURNAL (2021)

添加到收藏夹

Article Immunology

Individual functions of the histone acetyl transferases CBP and p300 in regulating the inflammatory response of synovial fibroblasts

Monika Krosel, Marcel Gabathuler, Malgorzata Maciukiewicz, Larissa Moser, Gideon Isaac Lee, Miriam Marks, Matija Tomsic, Oliver Distler, Caroline Ospelt, Kerstin Klein

Summary: In rheumatoid arthritis, chromatin remodeling and histone 3 lysine 27 acetylation are associated with sustained inflammatory responses in synovial fibroblasts. Writer proteins CBP and p300 have overlapping but distinct regulatory functions in controlling gene expression, with p300 being the major HAT for H3K27ac. Inhibition of CBP/p300 mirrors effects seen with p300 silencing, suggesting that inhibitors targeting these proteins may not be sufficient as anti-inflammatory drugs.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Article Health Care Sciences & Services

Wound Image Quality From a Mobile Health Tool for Home-Based Chronic Wound Management With Real-Time Quality Feedback: Randomized Feasibility Study

Jia Zhang, Carina Mihai, Laura Tueshaus, Gaetano Scebba, Oliver Distler, Walter Karlen

Summary: The study aimed to develop a mobile health tool for remote self-assessment of digital ulcers in SSc patients and demonstrated the feasibility of deploying such an app in this patient group. The feedback mechanism improved the overall image quality, marking a step towards reliable digital health solutions for home-based wound self-management.

JMIR MHEALTH AND UHEALTH (2021)

添加到收藏夹

Review Rheumatology

Purinergic signalling in systemic sclerosis

Jakob Hoeppner, Cosimo Bruni, Oliver Distler, Simon C. Robson, Gerd R. Burmester, Elise Siegert, Jorg H. W. Distler

Summary: SSc is a chronic autoimmune rheumatic disease with histopathological hallmarks including vasculopathy, fibrosis, and autoimmune phenomena. Purinergic signalling pathway may play a role in the pathophysiology of SSc, exacerbating vasculopathy and immune dysregulation, while also promoting organ and tissue fibrosis. Targeting purinergic signalling could offer new therapeutic options for SSc.

RHEUMATOLOGY (2022)

添加到收藏夹

Review Rheumatology

Skin biomarkers associated with complex regional pain syndrome (CRPS) Type I: a systematic review

Diana Andronic, Octavian Andronic, Astrid Juengel, Martin C. Berli, Oliver Distler, Florian Brunner

Summary: Despite ongoing research, the exact underlying processes of Complex Regional Pain Syndrome (CRPS) are still not well understood. This systematic review examines potential cutaneous biomarkers in CRPS and identifies the implications for various pathophysiological processes and skin morphology. The findings suggest involvement of inflammation, vascular dysregulation, small fiber neuropathy, and hypersensitivity. Additionally, skin morphology changes, including neurite loss, disturbed mast cell migration, and increased expression of alpha 1-adrenoceptors on keratinocytes, were observed. These results provide a foundation for future developments in diagnosis and potential therapeutic targets for CRPS Type I patients.

RHEUMATOLOGY INTERNATIONAL (2022)

添加到收藏夹

Article Rheumatology

Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

Eric L. Matteson, Clive Kelly, Joerg H. W. Distler, Anna-Maria Hoffmann-Vold, James R. Seibold, Shikha Mittoo, Paul F. Dellaripa, Martin Aringer, Janet Pope, Oliver Distler, Alexandra James, Rozsa Schlenker-Herceg, Susanne Stowasser, Manuel Quaresma, Kevin R. Flaherty

Summary: In fibrosing autoimmune disease-related interstitial lung diseases (ILDs) with a progressive phenotype, nintedanib demonstrated efficacy in slowing the rate of decline in forced vital capacity (FVC), with manageable adverse events.

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON

Yannick Allanore, Madelon C. Vonk, Oliver Distler, Arata Azuma, Maureen D. Mayes, Martina Gahlemann, Alexandra James, Veronika Kohlbrenner, Margarida Alves, Dinesh Khanna, Kristin B. Highland

Summary: Nintedanib can reduce the decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) and has consistent safety profile and FVC outcomes in both short-term and long-term use.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Letter Rheumatology

Prediction of histology by B-mode and PD-mode ultrasound across different joint locations and diseases

Raphael Micheroli, Chantal Pauli, Kristina Buerki, Philipp Rossbach, Oliver Distler, Caroline Ospelt, Adrian Ciurea

RMD OPEN (2022)

添加到收藏夹

Article Rheumatology

Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry

Raphael Micheroli, Seraphina Kissling, Kristina Buerki, Pascale Exer, Rene Braem, Michael J. Nissen, Burkhard Moeller, Michael Andor, Oliver Distler, Almut Scherer, Adrian Ciurea

Summary: The study findings suggest that TNFi can decelerate the radiographic progression of SIJ in patients with axSpA, especially when used for at least 1 year.

RMD OPEN (2022)

添加到收藏夹

Article Rehabilitation

A Multi-component Intervention (NEXpro) Reduces Neck Pain-Related Work Productivity Loss: A Randomized Controlled Trial Among Swiss Office Workers

Andrea Martina Aegerter, Manja Deforth, Thomas Volken, Venerina Johnston, Hannu Luomajoki, Holger Dressel, Julia Dratva, Markus Josef Ernst, Oliver Distler, Beatrice Brunner, Gisela Sjogaard, Markus Melloh, Achim Elfering

Summary: This study investigated the effect of a multi-component intervention on neck pain-related work productivity loss among Swiss office workers. The results showed that the intervention had a significant reduction in neck pain-related work productivity loss, with implications for employers, employees, and policy makers.

JOURNAL OF OCCUPATIONAL REHABILITATION (2023)

添加到收藏夹

Article Rheumatology

Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model

Alexandru Garaiman, Farhad Nooralahzadeh, Carina Mihai, Nicolas Perez Gonzalez, Nikitas Gkikopoulos, Mike Oliver Becker, Oliver Distler, Michael Krauthammer, Britta Maurer

Summary: The study aims to evaluate the performance of a vision transformer-based deep-learning model in identifying microangiopathy in NFC images of SSc patients and compare it with the performance of rheumatologists. The results show that the ViT performs well in identifying different microangiopathic changes, but there is still room for improvement in terms of reliability compared to rheumatologists.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes

Tea Gegenava, Federico Fortuni, Nina Marijn van Leeuwen, Anders H. Tennoe, Anna-Maria Hoffmann-Vold, Ruxandra Jurcut, Adrian Giuca, Laura Groseanu, Felix Tanner, Oliver Distler, Jeroen J. Bax, Jeska De Vries-Bouwstra, Nina Ajmone Marsan

Summary: This study aimed to assess the impact of sex differences on cardiovascular outcomes in patients with systemic sclerosis (SSc). The results showed that male SSc patients had a higher incidence of cardiovascular events, and the adjusted left ventricular global longitudinal strain may explain this gender difference in outcomes.

RMD OPEN (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.